Brain Advance Access originally published online on May 15, 2006
Brain 2006 129(7):1720-1731; doi:10.1093/brain/awl114
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PINK1 protein in normal human brain and Parkinson's disease
1 Department of Molecular Neuroscience, Institute of Neurology University College London 2 Medical Molecular Biology Unit, Institute of Child Health University College London 3 Queen Square Brain Bank, Institute of Neurology University College London 4 Reta Lila Weston Institute of Neurological Studies University College London 5 Birkbeck College University of London, London, UK
Correspondence to: Professor N Wood, Department of Molecular Neuroscience, Institute of Neurology, Queen Square, London WC1N 3BG E-mail: n.wood{at}ion.ucl.ac.uk
Parkinson's disease is a common incurable neurodegenerative disease whose molecular aetiology remains unclear. The identification of Mendelian genes causing rare familial forms of Parkinson's disease has revealed novel proteins and pathways that are likely to be relevant in the pathogenesis of sporadic Parkinson's disease. Recently, mutations in a novel gene, PINK1, encoding a 581 amino acid protein with both mitochondrial targeting and serine/threonine kinase domains, were identified as a cause of autosomal recessive parkinsonism. This provided important evidence for the role of the mitochondrial dysfunction and kinase pathways in neurodegeneration. In this study, we report the first characterization of the PINK1 protein in normal human and sporadic Parkinson's brains, in addition to Parkinson's cases with heterozygous PINK1 mutations. The possible role of the PINK1 protein was also assessed in a number of neurodegenerative diseases characterized by proteinaceous inclusions. For these studies, rabbit polyclonal antibodies were raised against two peptide sequences within the N-terminal hydrophilic loops of PINK1 protein. Using immunohistochemistry and western blotting we were able to demonstrate that PINK1 is a ubiquitous protein expressed throughout the human brain and it is found in all cell types showing a punctate cytoplasmic staining pattern consistent with mitochondrial localization. Fractionation studies of human and rat brain confirm that PINK1 is localized to the mitochondrial membranes. In addition, we show that PINK1 is detected in a proportion of Lewy bodies in cases of sporadic Parkinson's disease and Parkinson's disease associated with heterozygous mutations in the PINK1 gene, which are clinically and pathologically indistinguishable from the sporadic cases. PINK1 was absent in cortical Lewy bodies, in neurofibrillary tangles in Alzheimer's disease, progressive supranuclear palsy and corticobasal degeneration, and in the glial and neuronal 
-synuclein positive inclusions in multiple system atrophy. These studies provide for the first time in vivo morphological and biochemical evidence to support a mitochondrial localization of PINK1 and underpin the significance of mitochondrial dysfunction in the pathogenesis of nigral cell degeneration in Parkinson's disease.
Key Words: Parkinson's disease; PINK1; immunohistochemistry; genetics; brain
Abbreviations: CBD, corticobasal degeneration; IM, inner mitochondrial membrane; LB, Lewy body; MSA, multiple system atrophy; OM, outer mitochondrial membrane; PINK1-IR, PINK1 immunoreactivity; PSP, progressive supranuclear palsy
Received October 25, 2005. Revised January 29, 2006. Accepted April 4, 2006.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  D. Sha, L.-S. Chin, and L. Li Phosphorylation of parkin by Parkinson disease-linked kinase PINK1 activates parkin E3 ligase function and NF-{kappa}B signaling Hum. Mol. Genet., January 15, 2010; 19(2): 352 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Samann, J. Hegermann, E. von Gromoff, S. Eimer, R. Baumeister, and E. Schmidt Caenorhabditits elegans LRK-1 and PINK-1 Act Antagonistically in Stress Response and Neurite Outgrowth J. Biol. Chem., June 12, 2009; 284(24): 16482 - 16491. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Deng, M. W. Dodson, H. Huang, and M. Guo The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila PNAS, September 23, 2008; 105(38): 14503 - 14508. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J M Hagenah, B Becker, N Bruggemann, A Djarmati, K Lohmann, A Sprenger, C Klein, and G Seidel Transcranial sonography findings in a large family with homozygous and heterozygous PINK1 mutations J. Neurol. Neurosurg. Psychiatry, September 1, 2008; 79(9): 1071 - 1074. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. W. Franks, C. Scheele, R. J. F. Loos, A. R. Nielsen, F. M. Finucane, C. Wahlestedt, B. K. Pedersen, N. J. Wareham, and J. A. Timmons Genomic variants at the PINK1 locus are associated with transcript abundance and plasma nonesterified fatty acid concentrations in European whites FASEB J, September 1, 2008; 22(9): 3135 - 3145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Piccoli, M Ripoli, G Quarato, R Scrima, A D'Aprile, D Boffoli, M Margaglione, C Criscuolo, G De Michele, A Sardanelli, et al. Coexistence of mutations in PINK1 and mitochondrial DNA in early onset parkinsonism J. Med. Genet., September 1, 2008; 45(9): 596 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Zhou, Y. Huang, Y. Shao, J. May, D. Prou, C. Perier, W. Dauer, E. A. Schon, and S. Przedborski The kinase domain of mitochondrial PINK1 faces the cytoplasm PNAS, August 19, 2008; 105(33): 12022 - 12027. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Anichtchik, H. Diekmann, A. Fleming, A. Roach, P. Goldsmith, and D. C. Rubinsztein Loss of PINK1 Function Affects Development and Results in Neurodegeneration in Zebrafish J. Neurosci., August 13, 2008; 28(33): 8199 - 8207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Gautier, T. Kitada, and J. Shen From the Cover: Loss of PINK1 causes mitochondrial functional defects and increased sensitivity to oxidative stress PNAS, August 12, 2008; 105(32): 11364 - 11369. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Weihofen, B. Ostaszewski, Y. Minami, and D. J. Selkoe Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1 Hum. Mol. Genet., February 14, 2008; 17(4): 602 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Klein and M. G. Schlossmacher Parkinson disease, 10 years after its genetic revolution: Multiple clues to a complex disorder Neurology, November 27, 2007; 69(22): 2093 - 2104. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Exner, B. Treske, D. Paquet, K. Holmstrom, C. Schiesling, S. Gispert, I. Carballo-Carbajal, D. Berg, H.-H. Hoepken, T. Gasser, et al. Loss-of-Function of Human PINK1 Results in Mitochondrial Pathology and Can Be Rescued by Parkin J. Neurosci., November 7, 2007; 27(45): 12413 - 12418. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Scheele, A. R. Nielsen, T. B. Walden, D. A. Sewell, C. P. Fischer, R. J. Brogan, N. Petrovic, O. Larsson, P. A. Tesch, K. Wennmalm, et al. Altered regulation of the PINK1 locus: a link between type 2 diabetes and neurodegeneration? FASEB J, November 1, 2007; 21(13): 3653 - 3665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Thomas and M. F. Beal Parkinson's disease Hum. Mol. Genet., October 15, 2007; 16(R2): R183 - R194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Murakami, Y. Moriwaki, T. Kawarabayashi, M. Nagai, Y. Ohta, K. Deguchi, T. Kurata, N. Morimoto, Y. Takehisa, E. Matsubara, et al. PINK1, a gene product of PARK6, accumulates in {alpha}-synucleinopathy brains J. Neurol. Neurosurg. Psychiatry, June 1, 2007; 78(6): 653 - 654. [Full Text] [PDF]
|
|
|
|
 |
|
 W. Mandemakers, V. A. Morais, and B. De Strooper A cell biological perspective on mitochondrial dysfunction in Parkinson disease and other neurodegenerative diseases J. Cell Sci., May 15, 2007; 120(10): 1707 - 1716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Steinlechner, J. Stahlberg, B. Volkel, A. Djarmati, J. Hagenah, A. Hiller, K. Hedrich, I. Konig, C. Klein, and R. Lencer Co-occurrence of affective and schizophrenia spectrum disorders with PINK1 mutations J. Neurol. Neurosurg. Psychiatry, May 1, 2007; 78(5): 532 - 535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. Sim, D. S. S. Lio, S. S. Mok, C. L. Masters, A. F. Hill, J. G. Culvenor, and H.-C. Cheng C-terminal truncation and Parkinson's disease-associated mutations down-regulate the protein serine/threonine kinase activity of PTEN-induced kinase-1 Hum. Mol. Genet., November 1, 2006; 15(21): 3251 - 3262. [Abstract] [Full Text] [PDF]
|
|